The three options for payment are as follows:
1. Credit card payment online
2, Payment via cheque
3. Third-party payment via cheque or credit card

If paying by cheque, you will need to print the confirmation and mail it to us with payment at: CAPRA, 2425 Matheson Blvd. E, 7th Floor, Suite 795, Mississauga, ON L4W 5K4

Please note: Under the new incorporated CAPRA, credits for meetings can no longer be issued. In order to attend a meeting, payment must be received prior to the meeting registration deadline (either online or by mail). Please be advised that cheques should not be mailed less than a week prior to the meeting. Registrants for whom payment has not been received will be refused entry to the meeting.

Add the "Buy Tickets" option to your cart. After completing the checkout process, you will be provided with a link to the Event Registration form(s) where you can provide us with the details of the attendee(s). If you have registered for previous events, then you can simply confirm your previously submitted details, or make changes where needed.

Toronto Dinner Meeting

Date: Monday, Oct 22nd, 2018
Place: The Westin Bristol Place Toronto Airport
950 Dixon Road, Toronto, ON   M9W 5N4
Time: Registration and reception: 5:30-6:15 pm 
Presentation: 6:15-7:30 pm 
Dinner: 7:30 - 9:00 pm
Please Note: Registering for the Toronto Dinner meeting does not register you for AGM.
Dinner Meeting Title: E9 (R1): Estimands and Sensitivity Analysis in Clinical Trials (Addendum to ICH E9 – Statistical Principles for Clinical Trials)
Description:  An addendum to ICH E9 (Statistical Principles for Clinical Trials) is currently under development. The purpose of the addendum is to develop regulatory guidance, which promotes harmonised standards on the target of estimation (the estimand) in clinical trials, and describes an agreed framework for planning, conducting and interpreting sensitivity analyses. As with ICH E9, the Addendum will focus on statistical principles related to estimands and sensitivity analyses, not on the use or acceptability of specific statistical procedures or methods.

In this presentation, a new framework for aligning the estimand, the method of estimation (estimator), and sensitivity analyses for a given trial objective will be introduced.  The four attributes that together describe the estimand are discussed, as are the proposed strategies for addressing intercurrent events.  In the new framework, intercurrent events are defined as events that occur after treatment initiation and either preclude observation of the variable or affect its interpretation. With regards to the construction of estimands, general as well as therapeutic and experimental context considerations will be discussed. Finally, the presentation will address the impact of the new framework on trial design, conduct and analysis.

Speaker: Catherine Njue, PhD
Biostatistics Advisor – Clinical Trials, Biologics and Genetic Therapies Directorate, Health Canada
Dr. Catherine Njue is a Biostatistics Advisor for Clinical Trials in the Biologics and Genetic Therapies Directorate, Health Canada. In this position, she is primarily involved in evaluating the statistical methodology of clinical trials for biologics (e.g., vaccines, blood products) and related biotechnology products and radiopharmaceuticals. She also provides statistical expertise in the drafting, review and implementation of standards and guidelines developed by Health Canada, ICH, and WHO working groups.




Date:Monday, October 22, 2018
Place:The Westin Bristol Place Toronto Airport
950 Dixon Road
Toronto, ON M9W 5N4
Time:Registration and reception: 5:30-6:15 pm
Presentation: 6:15-7:30 pm
Dinner: 7:30-9:00 pm
Registration Deadline: Wednesday, October 17, 2018 4pm
Reservations or cancellations cannot be accepted after the deadline.